Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in Combination With Bortezomib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Clinical trial NCT00407303 · COMPLETED
Trial details
- NCT number
- NCT00407303
- Sponsor
- Gemin X
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2009-03-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.